Veeva Systems announced that Bayer will be among the first 20 major biopharmaceuticals to migrate to Veeva Vault CRM worldwide, while standardizing global data of customers with Veeva OpenData . As Bayer moves to Vault CRM, the next generation of CRM for life sciences, it is harmonizing customer reference data for greater efficiency and continued innovation...
Roche announced the launch of Elecsys HBeAg quant, an immunoassay that is able to determine both the presence and quantity of the hepatitis B e antigen in human serum and plasma. This launch means that, when combined with other laboratory results and clinical information, patients will now get confirmation...
STEMCELL Technologies, Canada's largest biotechnology company, has received the 2023 Canada's Most Admired Corporate Cultures award from Waterstone Human Capital. This national awards program recognizes best-in-class Canadian organizations for driving high-performance corporate cultures that help sustain a competitive advantage.
Also Read: Certara introduces Simcyp™ Biopharmaceutics software to increase efficiency of...
Veracyte, Inc. announced that seven posters will be presented at the 24th Annual Meeting of the Society of Urologic Oncology (SUO 2023), where they will demonstrate the clinical performance of Veracyte’s Decipher Prostate Genomic Classifier in identifying patients whose prostate cancer is likely to progress and require treatment. Collectively, the posters...
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company pursuing novel therapeutics for nonalcoholic steatohepatitis (NASH), announced that Ronald Filippo has been appointed Chief Information Officer.
Mr. Filippo has more than 25 years of digital experience in the biopharmaceutical industry and was previously Senior Vice President Digital at Moderna, where he was...
Simcyp Biopharmaceutics helps drug developers replace costly clinical bioequivalence studies and optimize formulations for complex therapies
Certara, Inc., a global leader in biosimulation, announced the introduction of Simcyp™ Biopharmaceutics software. It is designed for use by biopharmaceutic, formulation, and CMC scientists to aid in formulating complex novel and generic small...
BeiGene, Ltd., a global biotechnology company, and Ensem Therapeutics, Inc. (ENSEM), a biotechnology company focusing on high-value and difficult-to-drug oncology targets, announced an agreement for BeiGene to acquire an exclusive global license to an Investigational New Drug (IND) application-ready oral cyclin-dependent kinase 2 (CDK2) inhibitor.
“We are committed to developing...
Collaboration leverages expertise in artificial intelligence from Genentech and NVIDIA to unlock scientific innovation and empower R&D at a scale previously unattainable in pursuit of novel therapies
Genentech, a member of the Roche Group, announced a multi-year strategic research collaboration with NVIDIA that couples Genentech’s artificial intelligence (AI) capabilities, extensive...
Myricx Bio, a UK biotech company focused on the discovery and development of a completely novel class of antibody-drug conjugate (ADC) payloads based on N-Myristoyltransferase inhibition (NMTi), and WuXi Biologics (“WuXi Bio”) (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), today announce that they have entered...
New Advisory Brief Discusses Four Pillars to Focus Resource Allocation, Improve Patient Care and Provide Differentiated Patient Partnership
Trinity Life Sciences, a leader in global life sciences commercialization solutions, maps out investment strategies and tactics to calibrate a patient-centric approach in rare disease in its new advisory brief. The brief...
